Developmental Phase II
Showing 1 - 25 of >10,000
Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Tumor, Advanced Ovarian Carcinoma Trial in Bethesda, Boston (Biopsy,
Recruiting
- Advanced Fallopian Tube Carcinoma
- +21 more
- Biopsy
- +2 more
-
Bethesda, Maryland
- +2 more
Jan 25, 2023
SCN2A Encephalopathy, SCN8A Encephalopathy Trial in Tacoma (Part A: 0.5mg/kg/day PRAX-562 for 16 Weeks, Part A: 0.5mg/kg/day
Recruiting
- SCN2A Encephalopathy
- SCN8A Encephalopathy
- Part A: 0.5mg/kg/day PRAX-562 for 16 Weeks
- +2 more
-
Tacoma, WashingtonPraxis Research Site
Apr 18, 2023
Arthritis of Hip, Hip Dysplasia, Hip Arthropathy Trial (Stryker Trident® II HA coated cementless acetabula component)
Recruiting
- Arthritis of Hip
- +3 more
- Stryker Trident® II HA coated cementless acetabula component
-
Edinburgh, Lothian, United KingdomNHS Lothian
Sep 27, 2022
Intellectual Disability, Developmental Disability, Aggression Trial in Toronto (Nabilone)
Recruiting
- Intellectual Disability
- +3 more
-
Toronto, Ontario, CanadaCentre for Addiction and Mental Health
Mar 21, 2022
SCN8A Developmental and Epileptic Encephalopathy Syndrome Trial in United States (NBI-921352, Placebo)
Recruiting
- SCN8A Developmental and Epileptic Encephalopathy Syndrome
- NBI-921352
- Placebo
-
San Francisco, California
- +8 more
Nov 23, 2022
Child-family Social-emotional Health Trial in Springfield (SIB-Time web-application tool)
Not yet recruiting
- Child-family Social-emotional Health
- SIB-Time web-application tool
-
Springfield, OregonDavid R Smith
Oct 19, 2023
Pompe Telemedicine Developmental Study
Completed
- Pompe Disease
- Glycogen Storage Disease II
-
Durham, North CarolinaDuke University Medical Center
Oct 27, 2021
Advanced Bile Duct Carcinoma, Advanced Breast Carcinoma, Advanced Cervical Carcinoma Trial in United States (Cisplatin,
Recruiting
- Advanced Bile Duct Carcinoma
- +33 more
- Cisplatin
- +2 more
-
Sacramento, California
- +6 more
Aug 11, 2022
Prostate Cancer Trial in Beijing, Shanghai (Phase I:[177Lu]Lu-XT033 Injection, Phase II:[177Lu]Lu-XT033 Injection)
Not yet recruiting
- Prostate Cancer
- Phase I:[177Lu]Lu-XT033 Injection
- Phase II:[177Lu]Lu-XT033 Injection
-
Beijing, Beijing, China
- +1 more
Oct 7, 2023
Advanced Solid Tumor Trial in Shanghai (JS015, Toripalimab, Paclitaxel)
Not yet recruiting
- Advanced Solid Tumor
- JS015
- +10 more
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Nov 17, 2023
Mucopolysaccharidosis III-A Trial in Hamburg (JR-441)
Recruiting
- Mucopolysaccharidosis III-A
-
Hamburg, GermanyUniversitätsklinikum Hamburg-Eppendorf
Oct 18, 2023
MSI-H Colorectal Cancer, Tislelizumab, Oxaliplatin Trial (Tislelizumab)
Not yet recruiting
- MSI-H Colorectal Cancer
- +3 more
- (no location specified)
Apr 23, 2023
Developmental and Epileptic Encephalopathy, Dravet Syndrome, Lennox-Gastaut Syndrome Trial in United States (LP352)
Recruiting
- Developmental and Epileptic Encephalopathy
- +2 more
-
Little Rock, Arkansas
- +23 more
Jan 11, 2023
Metastatic Clear Cell Renal Cell Carcinoma, With Positive PSMA Expression at Tumor Sites Trial (177Lu-PSMA-1
Not yet recruiting
- Metastatic Clear Cell Renal Cell Carcinoma
- With Positive PSMA Expression at Tumor Sites
- 177Lu-PSMA-1 (radiopharmaceutical)
- (no location specified)
Sep 26, 2023
Osteoarthritis, Knee Trial in Taipei (2ccPA, Placebo)
Recruiting
- Osteoarthritis, Knee
- 2ccPA
- Placebo
-
Taipei, TaiwanTaipei Veterans General Hospital
Mar 28, 2023
Gastric Cancer, Pancreatic Cancer Trial (LM302+Toripalimab)
Not yet recruiting
- Gastric Cancer
- Pancreatic Cancer
- (no location specified)
Jun 28, 2023
Sarcoma Trial in Guangzhou (Fluzoparib+ Dalpiciclib)
Recruiting
- Sarcoma
- Fluzoparib+ Dalpiciclib
-
Guangzhou, Guangdong, ChinaCancer Center of Sun-Yat Sen University (CCSYSU)
Jul 11, 2023
Preterm Birth, Developmental Delay, Growth Delay Trial in Alkmaar (CBCL, SDQ, CCC-2-NL)
Enrolling by invitation
- Preterm Birth
- +2 more
- CBCL
- +8 more
-
Alkmaar, NetherlandsNoordwest Ziekenhuisgroep
Aug 6, 2023
Prostate Cancer Trial in Chicago (Docetaxel, ADT, Abiraterone)
Not yet recruiting
- Prostate Cancer
- Docetaxel
- +2 more
-
Chicago, IllinoisNorthwestern University
Sep 27, 2023
Hemorrhage Trial in Fort Worth (0 Hz Control, 0.1 Hz PPT, 0.05 Hz PPT)
Completed
- Hemorrhage
- 0 Hz Control
- +2 more
-
Fort Worth, TexasUniversity of North Texas Health Science Center
Aug 1, 2023
Metastatic Breast Cancer Trial in Birmingham (Capecitabine Pill)
Not yet recruiting
- Metastatic Breast Cancer
- Capecitabine Pill
-
Birmingham, AlabamaUniversity of Alabama at Birmingham
Oct 23, 2023
Laryngeal Carcinoma Trial in Dallas (LT-SABR, IMRT)
Not yet recruiting
- Laryngeal Carcinoma
- LT-SABR
- IMRT
-
Dallas, TexasUniversity of Texas Southwestern Medical Center
Oct 6, 2023